1Role of apoptosis-inducing factor in perinatal hypoxic-ischemic brain injuryJuan Rodriguez，Tao Li，Yiran Xu，Yanyan Sun，Changlian ZhuReviews205-213
2Therapeutic potential of neuromodulation for demyelinating diseasesElliot H. Choi，Chioma Nwakalor，Nolan J. Brown，Joonho Lee，Michael Y. Oh，In Hong YangReviews214-217
3Dysfunctional glia: contributors to neurodegenerative disordersMarta Sidoryk-W?grzynowicz，Lidia Stru?yńskaReviews218-222
4Inflammation/bioenergetics-associated neurodegenerative pathologies and concomitant diseases: a role of mitochondria targeted catalase and xanthophyllsMikhail A. Filippov，Olga G. Tatarnikova，Natalia V. Pozdnyakova，Vasily V. VorobyovReviews223-233
5Potential therapeutic effects of polyphenols in Parkinson's disease: in vivo and in vitro pre-clinical studiesClaudio Giuliano，Silvia Cerri，Fabio BlandiniReviews234-241
6Possible implications of dysregulated nicotinic acetylcholine receptor diffusion and nanocluster formation in myasthenia gravisFrancisco J. BarrantesReviews242-246
7Hydrogel-based local drug delivery strategies for spinal cord repairRobert B. Shultz，Yinghui ZhongReviews247-253
8Altered physiology of gastrointestinal vagal afferents following neurotraumaEmily N. Blanke，Gregory M. Holmes，Emily M. BeseckerReviews254-263
9Prospects for intelligent rehabilitation techniques to treat motor dysfunctionCong-Cong Huo，Ya Zheng，Wei-Wei Lu，Teng-Yu Zhang，Dai-Fa Wang，Dong-Sheng Xu，Zeng-Yong LiReviews264-269
11Membrane progesterone receptors (mPRs/PAQRs) in Schwann cells represent a promising target for the promotion of neuroregenerationLuca F. Castelnovo，Peter Thomas，Valerio MagnaghiPerspectives281-282
12Nanoparticles as a tool to deliver drugs to the retina and brain: an updateQing You，Bernhard A. SabelPerspectives283-284
13Stem cell heterogeneity and regenerative competence: the enormous potential of rare cellsEmily A.B. Gilbert，Cindi M. MorsheadPerspectives285-286
14Gut microbiota: a potential therapeutic target for Parkinson's diseaseJosé Fidel Baizabal-CarvalloPerspectives287-288
15Novel Galectin-3 interactions involved in oligodendroglial differentiation make inroads into therapeutic strategies for demyelinating diseasesLaura Andrea PasquiniPerspectives289-290
16Oligodendrocytes in a dish for the drug discovery pipeline: the risk of oversimplificationVito Antonio Baldassarro，Luciana Giardino，Laura CalzàPerspectives291-293
17The role of NLRP3 inflammasome for microglial response to peripheral inflammationOlga GaraschukPerspectives294-295
18Multi-omics insights into neuronal regeneration and re-innervationMuhammad Zain Chauhan，Sanjoy K. BhattacharyaPerspectives296-297
20Excitotoxicity-induced endocytosis as a potential target for stroke neuroprotectionMargarita Díaz-GuerraPerspectives300-301
